Charlottenlund, Denmark

Keld Danø


Average Co-Inventor Count = 11.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Keld Danø

Introduction

Keld Danø, a prominent inventor based in Charlottenlund, Denmark, has made significant strides in medical research through his innovations. With two patents to his name, his work primarily revolves around enhancing cancer treatment modalities and understanding crucial biological mechanisms.

Latest Patents

Danø's latest patents represent cutting-edge advancements in the field of cancer research. The first patent focuses on the urokinase-type plasminogen activator receptor. This invention outlines a method for inhibiting the conversion of plasminogen into plasmin by preventing the binding of a receptor form of urokinase-type plasminogen activator. This breakthrough has the potential to impact therapeutic approaches in mammals significantly.

His second patent addresses the suppression of inhibitors in malignant tumor growth, invasion, and metastasis. This invention discusses methods for inhibiting the activity of specific inhibitors present in tumor tissues. By administering compounds that interact with these inhibitors, Danø proposes new avenues for treating malignancies effectively.

Career Highlights

Throughout his career, Keld Danø has been associated with notable organizations such as the Cancer Research Fund of 1989. His contributions to cancer research have established him as a respected figure in the scientific community, particularly in the realm of therapeutic advancements. His work has paved the way for innovative treatment protocols that could transform the fight against cancer.

Collaborations

Danø has collaborated with esteemed colleagues like Vincent Ellis and Charles Pyke, whose partnership has fostered the exchange of valuable insights and expertise. This collaborative effort has been instrumental in enhancing the effectiveness of the research conducted and in achieving significant results in their joint ventures.

Conclusion

Keld Danø's contributions to the field of cancer research through his patents and collaborative efforts demonstrate the critical role of innovation in developing new therapeutic options. His work not only helps in understanding complex biological systems but also offers hope for improved treatment strategies in oncology. As he continues to explore the frontiers of medical science, Keld Danø remains a key figure to watch in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…